Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS | 12 | 3 | +65,75 % | ||
| ATAIBECKLEY | 7 | - | -3,27 % | ||
| GILEAD SCIENCES | 6 | 5 | -0,05 % | ||
| SOLID BIOSCIENCES | 6 | - | +20,43 % | ||
| IMMUNEERING | 6 | - | +6,81 % | ||
| BIONTECH | 3 | 13 | -0,51 % | ||
| INCYTE | 2 | 25 | -1,19 % | ||
| TANGO THERAPEUTICS | 2 | 3 | +0,77 % | ||
| ANAPTYSBIO | 2 | 2 | +1,26 % | ||
| CYTOKINETICS | 2 | 1 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:50 | ANAVEX LIFE SCIENCES CORP: Stabilität als Signal | 1 | Maximilian Berger | ||
| Fr | Oppenheimer bestätigt Immuneering-Rating nach Fortschritten in der Produktpipeline | 4 | Investing.com Deutsch | ||
| Fr | Oppenheimer reiterates Immuneering stock rating on pipeline progress | 1 | Investing.com | ||
| Fr | Tango Therapeutics Sub, Inc: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | AtaiBeckley Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | AtaiBeckley Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| Fr | INCYTE CORP - 8-K, Current Report | 5 | SEC Filings | ||
| Fr | Raymond James reiterates Legend Biotech stock rating after rival approval | 2 | Investing.com | ||
| Fr | Incyte Announces the European Commission Approval of Zynyz (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) | 385 | Business Wire | Zynyz (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe - The EC approval... ► Artikel lesen | |
| Fr | Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma | 1 | MedCity News | ||
| Fr | Savara receives FDA day 74 letter for autoimmune PAP drug | 2 | Investing.com | ||
| Fr | Servier Acquiring Day One Biopharmaceuticals For About $2.5 Billion | 1 | pulse2.com | ||
| Fr | Jefferies reiterates atai Life Sciences stock rating on pipeline progress | 2 | Investing.com | ||
| Fr | Nurix Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Solid Biosciences Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Jefferies bekräftigt Kaufempfehlung für atai Life Sciences nach Fortschritten in der Produktpipeline | 6 | Investing.com Deutsch | ||
| Fr | Absci Corp - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Leerink cuts CorMedix stock price target on expense adjustments | 5 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.